Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Clinical trial NCT05501665 · RECRUITING

Trial details

NCT number: NCT05501665
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage III Lung Cancer

Start date: 2023-05-09
Primary completion: 2026-02-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.